
### [MONDO:0002847](http://purl.obolibrary.org/obo/MONDO_0002847)
**Label:** skeletal muscle cancer

**Subclasses:** [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0009994](http://purl.obolibrary.org/obo/MONDO_0009994) (alveolar rhabdomyosarcoma (disease)), [MONDO:0016260](http://purl.obolibrary.org/obo/MONDO_0016260) (uterine corpus rhabdomyosarcoma), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0016282](http://purl.obolibrary.org/obo/MONDO_0016282) (rhabdomyosarcoma of the cervix uteri), [MONDO:0000756](http://purl.obolibrary.org/obo/MONDO_0000756) (parameningeal embryonal rhabdomyosarcoma), [MONDO:0002859](http://purl.obolibrary.org/obo/MONDO_0002859) (breast rhabdomyosarcoma), [MONDO:0002858](http://purl.obolibrary.org/obo/MONDO_0002858) (ovary rhabdomyosarcoma), [MONDO:0002853](http://purl.obolibrary.org/obo/MONDO_0002853) (rectum rhabdomyosarcoma), [MONDO:0002578](http://purl.obolibrary.org/obo/MONDO_0002578) (botryoid rhabdomyosarcoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0004513](http://purl.obolibrary.org/obo/MONDO_0004513) (adult pleomorphic rhabdomyosarcoma), [MONDO:0002574](http://purl.obolibrary.org/obo/MONDO_0002574) (prostate embryonal rhabdomyosarcoma), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0002851](http://purl.obolibrary.org/obo/MONDO_0002851) (mediastinum rhabdomyosarcoma), [MONDO:0002850](http://purl.obolibrary.org/obo/MONDO_0002850) (central nervous system rhabdomyosarcoma), [MONDO:0004012](http://purl.obolibrary.org/obo/MONDO_0004012) (adult botryoid rhabdomyosarcoma), [MONDO:0004013](http://purl.obolibrary.org/obo/MONDO_0004013) (adult vagina botryoid rhabdomyosarcoma), [MONDO:0004233](http://purl.obolibrary.org/obo/MONDO_0004233) (childhood pleomorphic rhabdomyosarcoma), [MONDO:0011655](http://purl.obolibrary.org/obo/MONDO_0011655) (alveolar soft part sarcoma (disease)), [MONDO:0002849](http://purl.obolibrary.org/obo/MONDO_0002849) (liver rhabdomyosarcoma), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0016095](http://purl.obolibrary.org/obo/MONDO_0016095) (vaginal rhabdomyosarcoma), [MONDO:0002864](http://purl.obolibrary.org/obo/MONDO_0002864) (anus rhabdomyosarcoma), [MONDO:0002863](http://purl.obolibrary.org/obo/MONDO_0002863) (mixed type rhabdomyosarcoma), [MONDO:0003994](http://purl.obolibrary.org/obo/MONDO_0003994) (vagina botryoid rhabdomyosarcoma), [MONDO:0002860](http://purl.obolibrary.org/obo/MONDO_0002860) (testis rhabdomyosarcoma), [MONDO:0003992](http://purl.obolibrary.org/obo/MONDO_0003992) (childhood botryoid rhabdomyosarcoma), [MONDO:0003993](http://purl.obolibrary.org/obo/MONDO_0003993) (childhood vagina botryoid rhabdomyosarcoma), [MONDO:0002581](http://purl.obolibrary.org/obo/MONDO_0002581) (spindle cell rhabdomyosarcoma), [MONDO:0006389](http://purl.obolibrary.org/obo/MONDO_0006389) (prostate rhabdomyosarcoma), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0006123](http://purl.obolibrary.org/obo/MONDO_0006123) (cardiac rhabdomyoma (disease)), 

**Mapped go classes:** [GO:1903243](http://purl.obolibrary.org/obo/GO_1903243) (negative regulation of cardiac muscle hypertrophy in response to stress), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0035947](http://purl.obolibrary.org/obo/GO_0035947) (regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0031062](http://purl.obolibrary.org/obo/GO_0031062) (positive regulation of histone methylation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0048659](http://purl.obolibrary.org/obo/GO_0048659) (smooth muscle cell proliferation), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0045722](http://purl.obolibrary.org/obo/GO_0045722) (positive regulation of gluconeogenesis), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia), [GO:0014813](http://purl.obolibrary.org/obo/GO_0014813) (skeletal muscle satellite cell commitment), [GO:0010453](http://purl.obolibrary.org/obo/GO_0010453) (regulation of cell fate commitment), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0032873](http://purl.obolibrary.org/obo/GO_0032873) (negative regulation of stress-activated MAPK cascade), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0050938](http://purl.obolibrary.org/obo/GO_0050938) (regulation of xanthophore differentiation), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0046324](http://purl.obolibrary.org/obo/GO_0046324) (regulation of glucose import), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0014807](http://purl.obolibrary.org/obo/GO_0014807) (regulation of somitogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0031401](http://purl.obolibrary.org/obo/GO_0031401) (positive regulation of protein modification process), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number) 52.00%
- [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance) 52.00%
- [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide) 52.00%
- [GO:0071731](http://purl.obolibrary.org/obo/GO_0071731) (response to nitric oxide) 52.00%
- [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia) 52.00%
- [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification) 52.00%
- [GO:0060592](http://purl.obolibrary.org/obo/GO_0060592) (mammary gland formation) 52.00%
- [GO:0055093](http://purl.obolibrary.org/obo/GO_0055093) (response to hyperoxia) 52.00%
- [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation) 52.00%
- [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development) 52.00%
- [GO:0036296](http://purl.obolibrary.org/obo/GO_0036296) (response to increased oxygen levels) 52.00%
- [GO:0036295](http://purl.obolibrary.org/obo/GO_0036295) (cellular response to increased oxygen levels) 52.00%
- [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development) 52.00%
- [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning) 52.00%


